Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Century Therapeutics Inc (IPSC)

Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Century Therapeutics Inc 25 N 38 th Street 11th Floor PHILADELPHIA PA 19104 USA

www.centurytx.com Employees: 150 P: 267-817-5790

Sector:

Medical

Description:

Century Therapeutics Inc. is a cell therapy company. It involved in developing induced pluripotent stem cell -derived cell therapies in immuno-oncology. Century Therapeutics Inc. is based in PHILADELPHIA.

Key Statistics

Overview:

Market Capitalization, $K 94,834
Enterprise Value, $K 36,474
Shares Outstanding, K 87,405
Annual Sales, $ 6,590 K
Annual Net Income, $ -126,570 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -32,540 K
EBIT, $ -28,230 K
EBITDA, $ -19,740 K
60-Month Beta 1.80
% of Insider Shareholders 4.37%
% of Institutional Shareholders 50.20%
Float, K 83,585
% Float 95.63%
Short Interest 246
Short Float 0.28%
Short Volume Ratio 0.33

Growth:

1-Year Return -8.64%
3-Year Return -78.85%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.32 on 11/13/25
Next Earnings Date 03/18/26
Earnings Per Share ttm -0.29
EPS Growth vs. Prev Qtr 15.79%
EPS Growth vs. Prev Year 13.51%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

IPSC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -10.01%
Return-on-Assets % -6.58%
Profit Margin % -1,920.64%
Debt/Equity 0.00
Price/Sales 13.80
Price/Cash Flow N/A
Price/Book 0.51
Book Value/Share 2.44
Interest Coverage -2.76
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar